As of Mar 16
| +0.05 / +1.84%|
The 4 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +98.56% increase from the last price of 2.77.
The current consensus among 4 polled investment analysts is to Buy stock in Aveo Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.